Current update in the management of diabetic nephropathy, Curr Diabetes Rev, vol.9, pp.62-77, 2013. ,
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice, Proc Natl Acad Sci U S A, vol.97, pp.8015-8020, 2000. ,
Mediators of diabetic renal disease: The case for tgf-Beta as the major mediator, J Am Soc Nephrol, vol.15, pp.55-57, 2004. ,
Pathology of human diabetic nephropathy, Contrib Nephrol, vol.170, pp.36-47, 2011. ,
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes, Diabetes Metab, vol.38, pp.102-112, 2012. ,
Update on potential drugs for the treatment of diabetic kidney disease, Clin Ther, vol.34, pp.1237-1246, 2012. ,
Limitations and future treatment options in type 2 diabetes with renal impairment, Diabetes Care, vol.34, pp.330-334, 2011. ,
Endothelin and podocyte injury in chronic kidney disease, Contrib Nephrol, vol.172, pp.120-138, 2011. ,
Role of endothelin-1 in clinical hypertension: 20 years on, Hypertension, vol.52, pp.452-459, 2008. ,
Endothelin-1 induces NF-kappaB via two independent pathways in human renal tubular epithelial cells, Am J Nephrol, vol.27, pp.294-300, 2007. ,
Endothelin signalling in the cardiac myocyte and its pathophysiological relevance, Curr Vasc Pharmacol, vol.3, pp.343-351, 2005. ,
Endothelin-1-induced signaling pathways in vascular smooth muscle cells, Curr Vasc Pharmacol, vol.5, pp.45-52, 2007. ,
Endothelin signaling and actions in the renal mesangium, Contrib Nephrol, vol.172, pp.50-62, 2011. ,
Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria, J Am Soc Nephrol, vol.12, pp.2321-2329, 2001. ,
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney, Kidney Int, vol.44, pp.36-42, 1993. ,
Endothelin B receptor-like immunoreactivity in podocytes of the rat kidney, Arch Histol Cytol, vol.65, pp.245-250, 2002. ,
Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney, J Histochem Cytochem, vol.54, pp.1193-1203, 2006. ,
Endothelins: Multifunctional renal peptides, Physiol Rev, vol.73, pp.375-411, 1993. ,
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways, J Clin Invest, vol.83, pp.336-342, 1989. ,
Role of endothelin as a mitogen in experimental glomerulonephritis in rats, Kidney Int, vol.49, pp.1320-1329, 1996. ,
Gene expression for endothelins and their receptors in glomeruli of diabetic rats, J Lab Clin Med, vol.122, pp.149-156, 1993. ,
Diabetes mellitus increases endothelin-1 gene transcription in rat kidney, Kidney Int, vol.58, pp.1534-1545, 2000. ,
Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative, Horm Res, vol.56, pp.165-171, 2001. ,
Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients, J Biol Regul Homeost Agents, vol.16, pp.114-117, 2002. ,
Endothelin-1 and endothelin A receptor immunoreactivity is increased in patients with diabetic nephropathy, Ren Fail, vol.34, pp.308-315, 2012. ,
Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys, Biochem Biophys Res Commun, vol.339, pp.65-70, 2006. ,
Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat, J Cardiovasc Pharmacol, vol.42, pp.48-54, 2003. ,
Nephroprotective effect of bosentan in diabetic rats, J Cardiovasc Pharmacol, vol.42, pp.752-756, 2003. ,
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism, J Am Soc Nephrol, vol.18, pp.143-154, 2007. ,
Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes, Diabetologia, vol.54, pp.979-988, 2011. ,
Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy, Nat Rev Nephrol, vol.6, pp.447-449, 2010. ,
Endothelin in diabetic renal disease, Contrib Nephrol, vol.172, pp.139-148, 2011. ,
Endothelin antagonists for diabetic and nondiabetic chronic kidney disease, Br J Clin Pharmacol, vol.76, pp.573-579, 2013. ,
, J Am Soc Nephrol, vol.25, pp.1050-1062, 2014.
, Podocyte Endothelin Receptor Type B in Diabetic Nephropathy
Endothelin antagonist as add-on treatment for proteinuria in diabetic nephropathy: Is there light at the end of the tunnel?, J Am Soc Nephrol, vol.22, pp.593-595, 2011. ,
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy, J Am Soc Nephrol, vol.22, pp.763-772, 2011. ,
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes, Am J Physiol Renal Physiol, vol.297, pp.1448-1456, 2009. ,
Podocytespecific expression of Cre recombinase in transgenic mice, Genesis, vol.35, pp.39-42, 2003. ,
GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism, J Clin Invest, vol.118, pp.3279-3290, 2008. ,
Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis, Proc Natl Acad Sci U S A, vol.106, pp.2806-2811, 2009. ,
Bagnato A: b-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced b-catenin signaling, Oncogene, vol.32, pp.5066-5077, 2013. ,
A novel cross-talk between endothelin-1 and cyclic AMP signaling pathways in the regulation of GLUT1 transcription in 3T3-L1 adipocytes, Cell Signal, vol.23, pp.901-910, 2011. ,
Wnt/betacatenin signaling promotes podocyte dysfunction and albuminuria, J Am Soc Nephrol, vol.20, 1997. ,
Wnt/b-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival, J Biol Chem, vol.286, pp.26003-26015, 2011. ,
High glucoseenhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor, Am J Physiol Endocrinol Metab, vol.282, pp.161-169, 2002. ,
In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: Implication for permselective dysfunction of chronic nephropathies, Am J Pathol, vol.166, pp.1309-1320, 2005. ,
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling, Am J Pathol, vol.169, 1965. ,
Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition, Hypertension, vol.44, pp.974-981, 2004. ,
Sustained Ca2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger, Can J Physiol Pharmacol, vol.86, pp.526-535, 2008. ,
Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization, Biophys J, vol.95, pp.483-492, 2008. ,
Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction ,
, Exp Biol Med (Maywood), vol.231, pp.840-846, 2006.
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease, Hypertension, vol.54, pp.113-119, 2009. ,
Endothelin receptor selectivity in chronic kidney disease: Rationale and review of recent evidence, Eur J Clin Invest, vol.39, pp.50-67, 2009. ,
Physiology and pathology of endothelin-1 in renal mesangium, Am J Physiol Renal Physiol, vol.285, pp.579-589, 2003. ,
Endothelin receptor blockade in patients with diabetic nephropathy, Contrib Nephrol, vol.172, pp.235-242, 2011. ,
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: A randomised trial, Diabetologia, vol.55, pp.600-607, 2012. ,
NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus, J Am Soc Nephrol, vol.21, pp.587-597, 2010. ,
NF-kB inhibition delays DNA damage-induced senescence and aging in mice, J Clin Invest, vol.122, pp.2601-2612, 2012. ,
Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene, J Am Soc Nephrol, vol.16, pp.2941-2952, 2005. ,
Podocyte loss and progressive glomerular injury in type II diabetes, J Clin Invest, vol.99, pp.342-348, 1997. ,
Podocyte number predicts longterm urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria, Diabetologia, vol.42, pp.1341-1344, 1999. ,
Glomerular epithelial cell products stimulate mesangial cell proliferation in culture, Kidney Int, vol.52, pp.733-741, 1997. ,
Paracrine role for TGF-b-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease, Histol Histopathol, vol.27, pp.1131-1141, 2012. ,
Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure, Am J Physiol Renal Physiol, vol.289, pp.692-698, 2005. ,
Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt, Hypertension, vol.48, pp.286-293, 2006. ,
Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines, Kidney Int, vol.66, pp.91-101, 2004. ,
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis, Nat Med, vol.17, pp.1242-1250, 2011. ,
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart, Am J Physiol, vol.277, pp.2458-2469, 1999. ,
, Endothelin Antagonists in Diabetic Nephropathy: Back to Basics, pp.869-871